We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Algeta Announces First Patient Treated in Phase II trial of Alpharadin to Treat Bone Metastases in Breast Cancer

News   Feb 02, 2010

 
Algeta Announces First Patient Treated in Phase II trial of Alpharadin to Treat Bone Metastases in Breast Cancer
 
 
 

RELATED ARTICLES

Placental Mitochondria Adapt When Mothers Have Poor Diets or Low Oxygen

News

Using mice to model conditions in the womb, Cambridge researchers have provided new insights on how the placenta regulates how much oxygen and nutrients it transports to babies during challenging pregnancies.

READ MORE

Infrared to Visible Light: A Novel Route to Photodynamic Therapy & Drug Development

News

Researchers have succeeded in developing a chemical process to absorb infrared light and re-emit it as visible energy, allowing innocuous radiation to penetrate living tissue and other materials without the damage caused by high-intensity light exposure.

READ MORE

New Biomarkers Detect 70% of Pancreatic Cancer, a Vast Improvement

News

A new approach to pancreatic cancer screening may help doctors detect the disease in people at high risk before it reaches more advanced and difficult-to treat stages.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE